Contact HealthDay
Tel: 203.855.1400 or E-mail

News By Specialty

Allergy
Anesthesiology
Cardiology
Cosmetic Surgery
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Practice
Gastroenterology
Geriatrics
Hematology & Oncology
HIV & AIDS
Infectious Disease
Internal Medicine
Nephrology
Neurology
Nursing
OBGYN & Women's Health
Ophthalmology
Orthopedics
Otolaryngology
Pain Management
Pathology
Pediatrics
Pharmacy
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Follow us on:

    


e-Healthcare Leadership Awards


Early Sulfonylureas Benefit Mice With Neonatal Diabetes
Subset of mice treated with a sulfonylurea have permanent remission from neonatal diabetes
This article is older than one year and is no longer available.

Copyright © 2011 HealthDay. All rights reserved.

September 2, 2014

Archive Search

By Keyword:
By Category:
By Topic:

Related Articles

Tax on Sugary Beverages Could Most Reduce Child Obesity

Report Highlights Progress, Challenges in Health IT

Gene Research Yields Insights Into Ebola Virus

Ebola Outbreak Could Infect 20,000 People, U.N. Says

Long-Term Use of Sulfonylureas Tied to Coronary Heart Disease

CDC: Most U.S. Toddlers Getting Their Vaccines